Herber, S; Otto, G; Wörns, MA et al.
Single center experience over a 5-year period with sequential transarterial chemoembolisation (TACE) in the treatment of hepatocellular carcinoma (HCC)Rofo. Bd. 179. H. 3. 2007 S. 289-299
Fottner, C; Helisch, A; Musholt, PB et al.
Superiority of 6-[18F]-Fluordopamin positron Emission Tomography (DOPA-PET) versus [123J]-Metaiodobenzylguanidine (MIBG) Scintigraphy in the localization of extraadrenal or multifocal pheochromocytomas and paragangliomas.Langenbecks Arch Surg. Bd. 392. H. 6. 2007 S. P32
Moench, C; Barreiros, AP; Schuchmann, M et al.
Tacrolimus monotherapy without steroids after liver transplantation - A prospective randomized double-blinded placebo-controlled trialAm J Transplant. Bd. 7. 2007 S. 1616-1623
Hildner, KM; Schirmacher, P; Atreya, I et al.
Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis.J Immunol. Bd. 178. H. 6. 2007 S. 3427-36
Kiesslich, R; Götz, M; Vieth, M et al.
Technology insight: confocal laser endoscopy for in vivo diagnosis of colorectal cancer.Nat Clin Pract Oncol. Bd. 4. H. 8. 2007 S. 480-490
Moller, M; Herzer, K; Wenger, T et al.
The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells.Oncol Rep. Bd. 18. H. 3. 2007 S. 737-44
Fottner, C; Spöttl, G; Weber, MM
The divergent effect of insulin-like growth factor binding protein (IGFBP) – 1 on IGF-induced steroidogenesis in bovine adrenocortical cells is not due to its phosphorylation status.Exp Clin Endocr Diab. Bd. 115. 2007 S. 232-239
Moehler, M; Galle, PR; Gockel, I et al.
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.Best Pract Res Clin Gastroenterol. Bd. 21. H. 6. 2007 S. 965-81
Atreya, I; Schimanski, CC; Becker, C et al.
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer.Gut. Bd. 56. H. 11. 2007 S. 1572-8
Aigner, K; Dampier, B; Descovich, L et al.
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.Oncogene. Bd. 26. H. 49. 2007 S. 6979-88